The Guardian reported this week on a new study that estimates about 75% of former NFL players who died over a 15-year period had evidence of chronic traumatic encephalopathy (CTE). The research, published in JAMA Network Open, looked at prevalence in 2,362 players who died from 2008 to 2023. It is serious work, and it is worth understanding what it measures before you let any headline shape a decision about your own health.
What the number actually measures
Prevalence is a count of how often something appears in a defined group. In this case the group is people who had already died, and the finding describes how often a particular condition was present among them. That is a population answer. It helps researchers and the public understand how common a finding was in this group, and it helps shape questions about head impacts across a sport.
Group estimates also depend on who was counted, how they were examined and over which years. That is why the methods section of any study matters more than the percentage in a headline. Two studies with different groups or different methods can produce very different numbers, even when both are careful.
A group estimate does not tell a living reader whether they have the condition, how far along it might be or what will happen next. It describes many lives at once. Your situation is one life, with its own history, its own symptoms and its own examination findings. Those are the things a licensed clinician can actually assess.
Why a headline is not a personal result
Research news moves fast, and a striking percentage can feel like a verdict. Treat it as a reason to ask better questions rather than as a result you already have. If a study about one group makes you wonder about your own history, that wondering is a fair starting point for a conversation. It is not a finding about you.
Each new study adds one piece to a larger body of research. Single reports rarely settle a question on their own, and they often raise follow-up questions that take years to answer. Reading them as one piece, rather than as the final word, keeps expectations realistic.
Many readers also overlook the difference between what a research team can observe and what an office can observe. Researchers working with records of players who died can examine evidence in ways no first visit can. An examiner working with a living patient relies on history, examination and, when appropriate, referral for imaging or other tests chosen by the clinician. Neither replaces the other, and neither should be used as a reason to skip the other.
A plain way to use this news this week
If this study has you thinking about your own history, bring that question to a licensed clinician in plain words. Describe what you are noticing now, how long it has been going on and what worries you most. You do not need the big answer before you ask the smaller, practical questions. A clinician can help you sort out which concerns are worth a closer look and which can be monitored.
Keep the conversation focused on the present and on what you can describe accurately. Vague fears are harder to act on than specific observations, and a short, factual account of your current symptoms gives a clinician more to work with than a long list of worries from a news story.
What to watch for in the meantime
Waiting for an appointment should never mean ignoring changes that feel urgent. A sudden severe headache, confusion, weakness or numbness on one side of the body, trouble speaking, vision loss, or a head injury followed by vomiting or worsening drowsiness calls for emergency care now, not a scheduled visit. Mild, ongoing concerns can be discussed at a regular appointment, but the timing of care is a clinician's call, and a news story cannot make that call for you.
This article describes how to read research. It is not a diagnosis of anyone's brain. If you are in the St. Louis area and want to talk through symptoms that have been bothering you, a licensed clinician can review your history in person and explain what they can and cannot tell from it.